USPTO serial 79218573
STRAIGHT FROM
Reviewed by CopyMark Law Group
Reg. 5614037Status 707Registered
- Filing date
- Status date
- Registration date
- Nov 27, 2018
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with STRAIGHT FROM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DE
DE
Bergisch Gladbach, DE
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical, ] biological and biochemical products for industrial, scientific and non-medical diagnostic purposes, namely, [ chemicals, ] biological preparations and biochemicals for use in separation processes for biological materials; reagents for scientific and research use, namely, for use in separation processes for biological materials; reagents for cell separation for scientific and research use; cell labeling reagents for scientific and research use; [ substances and ingredients, namely, biological and chemical substances all for the preparation of cell culturing media, and all for scientific purposes and for the use in medical laboratories; ] reagents for scientific and research use, namely, for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials; reagents with magnetic beads for scientific and research use; antibody reagents, other than for medical or veterinary purposes; [ buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments, and other than for medical or veterinary purposes; ] reagents for processing of biological materials, especially tissue, bone marrow, cells, blood and its components, and other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; [ microorganism culture media, cell culture media, contrast agents, and contrast agents for in-vivo imaging, all for scientific purposes; chemical and ] biological reagents, other than for medical or veterinary purposes, namely, for use in biotechnology, in biological treatment processes and in the biotechnology industry | ACTIVE | — |
| 005 | [ Pharmaceutical, medical and veterinary products as well as ] products for the pharmaceutical, medical and veterinary science, namely, cell culture media and reagents for use in separation processes for biological materials for medical or veterinary purposes; [ pharmaceutical and other preparations for medical or veterinary purposes, namely, cell culture media and ] reagents for use in separation processes for biological materials; [ chemical and biological reagents for medical or veterinary purposes; cell culturing media for cultivating stem cells, tissue cells, immune cells and microorganism cells all for medical or veterinary purposes; ] reagents for medical use, namely, for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of biological materials; reagents with magnetic beads and antibody reagents, all for medical or veterinary purposes; [ buffer solutions and ] reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments and all for medical purposes; reagents for the processing of biological materials, especially tissue, bone marrow, cells, blood and its components, and all for medical or veterinary purposes; [ cell culture media for cultivating stem cells, tissue cells, immune cells and microorganisms, and diagnostic reagents and preparations all for medical and veterinary purposes; contrast agents, and contrast agents for in-vivo imaging, all for medical and veterinary purposes; ] pharmaceutical products, namely, pharmaceutical preparations for cellular therapy | ACTIVE | — |
| 009 | [ Scientific, optical and measuring apparatus and instruments, namely, instruments for the separation, analysis, processing and cultivation of biological material all for scientific or laboratory use; apparatus for recording, transmission or reproduction of images; data processing equipment; computer software for recording data related to the separation, analysis processing, and cultivation of biological material; scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions, namely, laboratory chemical reactors for use in separation processes for biological materials; laboratory equipment, namely, cytometer for measuring physical and chemical properties of cells and other particles in suspensions ] | SECTION 71 - CANCELLED | — |
| 010 | [Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, apparatus for magnetic cell separation for use in separation processes for biological materials; tubing sets for medical purposes, namely, drainage and transfusion tubing sets for medical purposes; sacks, bags, sheets, tubes and connectors for medical and medical biotechnological purposes, in particular for the collection of biological material for cryopreservation; apparatus and instruments for medical and biotechnological purposes, namely, apparatus for magnetic cell separation for use in separation processes for biological materials all for medical purposes; accessories for the aforesaid goods, namely, medical bags, sack tubes, and connectors for use in separation processes for biological materials for medical purposes and structural replacement parts for the aforesaid goods] | SECTION 71 - CANCELLED | — |
| 042 | [Scientific and technological services, namely, scientific research, analysis and testing in the fields of cell separation and isolation and new product research and design services relating hereto; industrial analysis and research services in the field of cell separation and isolation; design and development of computer hardware and software for use in the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named STRAIGHT FROM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 5, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 5, 2026 | INPC | INVALIDATION PROCESSED | — |
| Dec 15, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 15, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 15, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 12, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 27, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 5, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 22, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 6, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 6, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 28, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 27, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 11, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 11, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 22, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 22, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 2, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 2, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 2, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 31, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 7, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 3, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2017 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 24, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 3, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 3, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 20, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |